Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly logo
Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly Updated August 04, 2026

Needle‑free allergy treatment with medical oversight

Why “needle‑free” matters—and how it works

Needle‑free allergy treatment refers to sublingual immunotherapy (SLIT), where tiny, standardized doses of allergen are placed under the tongue to retrain the immune system. SLIT is delivered in two forms:

  • FDA‑approved tablets for specific allergens (grass, ragweed, dust mite)

  • Physician‑directed liquid drops compounded from FDA‑approved extracts (widely used off‑label in the U.S., on‑label in many countries)

For tablets, the U.S. Food & Drug Administration lists four products: Grastek (timothy grass), Oralair (5‑grass mix), Ragwitek (short ragweed), and Odactra (house dust mite). In February 2025, FDA expanded Odactra’s indication to ages 5–11; tablets must carry a boxed warning and require an epinephrine prescription for emergencies.

For clinical guidance and safety practices, see the patient and clinician resources from the national specialty societies: AAAAI and ACAAI.

Medical oversight comes first

  • First‑dose supervision: For tablets, the first dose is administered under medical supervision and patients are prescribed epinephrine for home use.

  • Candidate screening: Board‑certified allergists screen for uncontrolled asthma, EoE, MCAS, medication conflicts (e.g., beta‑blockers), pregnancy, and other contraindications.

  • Monitoring and escalation: Tablets follow labeled dosing; drops follow peer‑reviewed, clinician‑directed protocols with regular check‑ins.

Tablets: when to start and how to time a season

The AAAAI provides practical timing recommendations for the FDA‑approved SLIT tablets. Use this quick reference to plan—and avoid missed seasons:

Allergen Brand (generic) When to start Daily use pattern First dose
Grass (timothy) Grastek (timothy grass) Begin ~12 weeks before grass season 1 tablet daily through the season In‑office, then home use
Grass (5‑grass mix) Oralair (sweet vernal, orchard, perennial rye, timothy, Kentucky blue) Start at least 4 months before grass season 1 tablet daily through the season In‑office, then home use
Ragweed Ragwitek (short ragweed) Begin ~12 weeks before ragweed season 1 tablet daily through the season In‑office, then home use
Dust mite Odactra (HDM) Year‑round (no season) 1 tablet daily all year In‑office, then home use

Sources: AAAAI SLIT tablets guide and the FDA product pages.

SLIT vs. allergy shots (SCIT): how to choose

Both SCIT and SLIT are disease‑modifying immunotherapy. SCIT treats multiple allergens in one build‑up/maintenance program but requires clinic injections and 30‑minute observation due to rare anaphylaxis risk. SLIT tablets are needle‑free, taken at home after the supervised first dose, and tablet indications are limited to grass/ragweed/dust‑mite in the U.S. SLIT liquid drops are an off‑label, physician‑directed option when patients need multi‑allergen or non‑tablet coverage.

Evidence, safety, and what to expect

  • Efficacy: Major specialty societies (AAAAI/ACAAI) recognize immunotherapy as the only treatment that modifies allergic disease by inducing tolerance; tablets are FDA‑approved for defined allergens and have labeled efficacy and safety.

  • Safety: Tablets carry a boxed warning and require first‑dose supervision and an epinephrine prescription; serious reactions are rare with proper selection and monitoring.

  • Timeline: Many patients report improved symptoms between 4 weeks and 6 months; full, durable benefit typically requires ~3 years of continuous therapy.

How Wyndly delivers needle‑free, doctor‑led care

Wyndly is a physician‑led allergy practice focused on environmental allergens (not food). Care is delivered fully at home with continuous medical oversight:

  • Diagnostic options: At‑home, CLIA‑certified blood test for 40+ indoor/outdoor allergens with board‑certified physician review.

  • Treatment paths:

  • FDA‑approved tablets (grass, ragweed, dust‑mite) when indicated (first dose supervised locally).

  • Personalized SLIT drops for multi‑allergen coverage using FDA‑approved extracts and clinically backed dosing.

  • Access & pricing: Unlimited doctor support; transparent membership (typically $99/month) with a 90‑day “Allergy‑Free” money‑back promise if you don’t improve after following your plan.

  • Pediatric care: Wyndly treats ages 5+; for dust‑mite tablets specifically, FDA expanded Odactra to ages 5–11 on Feb 28, 2025—your Wyndly physician will confirm eligibility.

Who should not use SLIT

Do not start SLIT (tablets or drops) without physician guidance if you have uncontrolled or severe asthma, a history of EoE, MCAS, are pregnant, or take certain medicines (e.g., beta‑blockers). Your Wyndly physician will screen you and coordinate alternatives.

Fast, safe next steps

  • Use AAAAI/ACAAI guidance to time tablets before your next season.

  • Prefer a multi‑allergen, needle‑free plan with 24/7 medical access? Start Wyndly’s doctor‑led SLIT program.